TENET HEALTHCARE CORP
THCAPI behind this page
THC Q1 2026 request
Playground key active
/api/financials?ticker=THC&year=2026&quarter=1
Pick an endpoint and run the request.
Income Statement
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Revenue | 5,368 | 5,223 | +2.8% |
Show Product Lines breakouts |
|||
| Health Care Patient Service · Ambulatory Care | 1,266 | 1,143 | +10.8% |
| Indemnity and other · Hospital Operations | 150 | 117 | +28.2% |
| Managed care · Hospital Operations | 2,394 | 2,400 | -0.2% |
| Medicaid · Hospital Operations | 356 | 380 | -6.3% |
| Medicare · Hospital Operations | 565 | 548 | +3.1% |
| Other revenues · Hospital Operations | 574 | 549 | +4.6% |
| Revenue from other sources · Ambulatory Care | 54 | 51 | +5.9% |
| Total · Hospital Operations | 3,474 | 3,480 | -0.2% |
| Uninsured · Hospital Operations | 9 | 35 | -74.3% |
Show Business Segments breakouts |
|||
| Ambulatory Care | 1,320 | 1,194 | +10.6% |
| Ambulatory Care · Operating Segments | 1,320 | 1,194 | +10.6% |
| Ambulatory Care · Operating Segments | 1,320 | 1,194 | +10.6% |
| Hospital Operations · Operating Segments | 4,048 | 4,029 | +0.5% |
| Hospital Operations · Operating Segments | 4,048 | 4,029 | +0.5% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | 882 | 859 | +2.7% |
Show Statement Operating Activities Segment breakouts |
|||
| Segment Continuing Operations | 5,368 | 5,223 | +2.8% |
| Gain Loss On Contract Termination | 413 | — | — |
| Income Loss From Equity Method Investments | 51 | 56 | -8.9% |
Show Business Segments breakouts |
|||
| Ambulatory Care · Operating Segments | 51 | 54 | -5.6% |
| Labor And Related Expense | 2,174 | 2,119 | +2.6% |
Show Business Segments breakouts |
|||
| Ambulatory Care · Operating Segments | 330 | 295 | +11.9% |
| Hospital Operations · Operating Segments | 1,844 | 1,824 | +1.1% |
| Supplies Expense | 961 | 907 | +6.0% |
Show Business Segments breakouts |
|||
| Ambulatory Care · Operating Segments | 357 | 318 | +12.3% |
| Hospital Operations · Operating Segments | 604 | 589 | +2.5% |
| Other Cost And Expense Operating | 1,122 | 1,090 | +2.9% |
Show Business Segments breakouts |
|||
| Ambulatory Care · Operating Segments | 200 | 179 | +11.7% |
| Hospital Operations · Operating Segments | 922 | 911 | +1.2% |
| Depreciation & Amortization | 229 | 206 | +11.2% |
Show Business Segments breakouts |
|||
| Ambulatory Care · Operating Segments | 41 | 39 | +5.1% |
| Hospital Operations · Operating Segments | 188 | 167 | +12.6% |
Show Consolidation Items breakouts |
|||
| Operating Segments | 229 | 206 | +11.2% |
| Restructuring Settlement Impairment Provisions And Acquisition Cost | 24 | 19 | +26.3% |
| Litigation Settlement Expense | 27 | 17 | +58.8% |
| Net Gains Losses On Sale Consolidation And Deconsolidation Of Facilities | -1 | -22 | +95.5% |
| Operating Income | 1,296 | 943 | +37.4% |
| Interest Expense | -205 | -204 | -0.5% |
| Other Non-Operating Income (Expense) | 41 | 26 | +57.7% |
| Income Loss Including Portion Attributable To Noncontrolling Interest | 1,132 | 765 | +48.0% |
| Income Tax Expense (Benefit) | -226 | -143 | -58.0% |
| Net Income | 906 | 622 | +45.7% |
Show Equity Method Investment Nonconsolidated Investee breakouts |
|||
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | 213 | 215 | -0.9% |
| Net Income Loss Attributable To Noncontrolling Interest | 204 | 216 | -5.6% |
| Net Income Loss Available To Common Stockholders Basic | 702 | 406 | +72.9% |
| EPS (Basic) | 8.09 | 4.31 | +87.7% |
| EPS (Diluted) | 8.01 | 4.27 | +87.6% |
| Wtd Avg Shares (Basic) | 86,801 | 94,242 | -7.9% |
| Wtd Avg Shares (Diluted) | 87,596 | 95,019 | -7.8% |
| Income Before Taxes | 1.13 | 765 | -99.9% |
| Comprehensive Income | 704 | 408 | +72.5% |
Balance Sheet
| Metric | Q1 2026 | Q1 2025 | YoY |
|---|---|---|---|
| Current Assets | |||
| Cash & Cash Equivalents | 2,967 | 3 | +98833.0% |
Show Legal Entity breakouts |
|||
| Captive Insurance Subsidiaries | 107 | 109 | -1.8% |
| Accounts Receivable | 2,605 | — | — |
Show Accounts Notes Loans And Financing Receivable By Receivable Type breakouts |
|||
| California's Provider Fee Program | 401 | — | — |
| Inventory | 343 | 344 | -0.3% |
| Assets Of Disposal Group Including Discontinued Operation Current | 62 | 21 | +195.2% |
| Other Assets Current | 2,379 | 1,930 | +23.3% |
| Total Current Assets | 8,356 | 7,913 | +5.6% |
| Non-Current Assets | |||
| Deferred Tax Assets | 84 | 78 | +7.7% |
| Goodwill | 11,387 | 10,786 | +5.6% |
Show Business Segments breakouts |
|||
| Ambulatory Care | 8,690 | 8,089 | +7.4% |
| Hospital Operations | 2,697 | 2,697 | 0.0% |
Show Business Acquisition breakouts |
|||
| Series Of Individually Immaterial Business Acquisitions | 191 | 95 | +101.1% |
| Total Assets | 31,203 | — | — |
Show Business Segments breakouts |
|||
| Ambulatory Care | 13,273 | — | — |
| Hospital Operations | 17,930 | — | — |
| Intangible Assets | 432 | 518 | -16.6% |
Show Finite Lived Intangible Assets By Major Class breakouts |
|||
| Computer Software Intangible Asset | 333 | 400 | -16.8% |
| Contract Based Intangible Assets | 71 | 103 | -31.1% |
| Other Intangible Assets | 28 | 15 | +86.7% |
| Other Assets | |||
| Long Term Investments And Receivables Net | 3,809 | 3,069 | +24.1% |
| Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization | 6,251 | 5,991 | +4.3% |
| Intangible Assets Net Excluding Goodwill | 1,316 | 1,400 | -6.0% |
| Current Liabilities | |||
| Long Term Debt And Capital Lease Obligations Current | 81 | 88 | -8.0% |
| Accounts Payable | 1,339 | 1,327 | +0.9% |
| Employee Related Liabilities Current | 854 | 710 | +20.3% |
| Self Insurance Reserve Current | 303 | 268 | +13.1% |
| Interest Payable Current | 256 | 248 | +3.2% |
| Accrued Income Taxes Current | 236 | 149 | +58.4% |
| Other Liabilities Current | 3,083 | — | — |
| Total Current Liabilities | 6,152 | 4,451 | +38.2% |
| Deferred Revenue (Current) (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Hospital Operations | 1,406 | 105 | +1239.0% |
| Non-Current Liabilities | |||
| Self Insurance Reserve Noncurrent | 938 | 877 | +7.0% |
| Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent | 243 | 297 | -18.2% |
| Deferred Tax Liabilities | 199 | 226 | -11.9% |
| Other Non-Current Liabilities | 1,693 | 1,651 | +2.5% |
| Total Liabilities | 22,353 | 20,584 | +8.6% |
| Contract With Customer Liability Noncurrent (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Hospital Operations | 5 | 13 | -61.5% |
| Other Liabilities | |||
| Long Term Debt And Capital Lease Obligations | 13,128 | 13,082 | +0.4% |
| Redeemable Noncontrolling Interest Equity Carrying Amount | 2,137 | 2,776 | -23.0% |
| Stockholders' Equity | |||
| Common Stock | 8 | 8 | 0.0% |
| Additional Paid-In Capital | 5,124 | 4,826 | +6.2% |
| Accumulated Other Comprehensive Income | -179 | -178 | -0.6% |
| Retained Earnings | 5,117 | 3,414 | +49.9% |
| Treasury Stock Common Value | -5,256 | -3,889 | -35.2% |
| Total Stockholders' Equity | 4,814 | 4,181 | +15.1% |
| Minority Interest | 1,899 | 1,696 | +12.0% |
| Stockholders Equity Including Portion Attributable To Noncontrolling Interest | 6,713 | 5,877 | +14.2% |
Show Business Segments breakouts |
|||
| Ambulatory Care · Noncontrolling Interest | 1,683 | — | — |
| Hospital Operations · Noncontrolling Interest | 216 | — | — |
Show Equity Components breakouts |
|||
| Accumulated Other Comprehensive Income | -179 | -178 | -0.6% |
| Additional Paid In Capital | 5,124 | 4,826 | +6.2% |
| Common Stock | 8 | 8 | 0.0% |
| Noncontrolling Interest | 1,899 | 1,696 | +12.0% |
| Retained Earnings | 5,117 | 3,414 | +49.9% |
| Treasury Stock Common | -5,256 | -3,889 | -35.2% |
| Total Liabilities & Equity | 31,203 | 29,237 | +6.7% |
Cash Flow Statement
| Metric | YTD Q1 2026 | YTD Q1 2025 | YoY |
|---|---|---|---|
| Operating Activities | |||
| Deferred Income Taxes | -40 | 4 | -1100.0% |
| Stock-Based Compensation | 25 | 21 | +19.0% |
| Gain Loss Related To Litigation Settlement | 27 | 17 | +58.8% |
Show Litigation Status breakouts |
|||
| Pending Litigation | 27 | 17 | +58.8% |
| Net Losses On Sale Consolidation And Deconsolidation Of Facilities | -1 | -22 | +95.5% |
| Income Loss From Equity Method Investments Net Of Dividends Or Distributions | 29 | 5 | +480.0% |
| Amortization Of Financing Costs And Discounts | 5 | 6 | -16.7% |
| Gain Loss On Disposition Of Assets1 | -1 | — | — |
| Other Non-Cash Items | 2 | 2 | 0.0% |
| Change in Accounts Receivable | -28 | -69 | +59.4% |
| Increase Decrease In Inventories And Other Assets Current | 407 | -108 | +476.9% |
| Increase Decrease In Income Taxes Receivable | 259 | 132 | +96.2% |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -145 | 24 | -704.2% |
| Net Cash from Operations | 1,641 | 815 | +101.3% |
| Change in Deferred Revenue (Q) | — | — | — |
Show Business Segments breakouts |
|||
| Hospital Operations · Long Term Contract With Customer | -8 | — | — |
| Hospital Operations · Short Term Contract With Customer | 1,318 | 25 | +5172.0% |
| Investing Activities | |||
| Capital Expenditures | -180 | -173 | -4.0% |
| Payments To Acquire Businesses Net Of Cash Acquired | -121 | -27 | -348.1% |
Show Business Acquisition breakouts |
|||
| Series Of Individually Immaterial Business Acquisitions | -120 | -17 | -605.9% |
| Proceeds From Divestiture Of Businesses | 2 | 11 | -81.8% |
| Proceeds From Sale Of Marketable Securities Long Term Investments And Other Assets | 22 | 14 | +57.1% |
| Payments To Acquire Investments | -26 | -17 | -52.9% |
| Other Investing Activities | -14 | 5 | -380.0% |
| Net Cash from Investing | -317 | -187 | -69.5% |
| Financing Activities | |||
| Debt Repayments | -33 | -32 | -3.1% |
| Proceeds From Issuance Of Debt | 14 | 1 | +1300.0% |
| Share Repurchases | -318 | -348 | +8.6% |
| Payments Of Dividends Minority Interest | -197 | -189 | -4.2% |
| Proceeds From Sale Of Interest In Corporate Unit | 6 | 11 | -45.5% |
| Payments To Minority Shareholders | -549 | -41 | -1239.0% |
| Tax Withholding for Share Compensation | -86 | -32 | -168.8% |
| Proceeds From Payments For Other Financing Activities | -77 | -7 | -1000.0% |
| Net Cash from Financing | -1,240 | -648 | -91.4% |
| Supplemental | |||
| Interest Paid | -24 | -99 | +75.8% |
| Income Taxes Paid | -8 | -7 | -14.3% |
| Unpaid Capital Expenditures | 44 | — | — |
| Other Cash Flow | |||
| Payments For Restructuring And Litigation Costs | -57 | -36 | -58.3% |
| Net Change in Cash | 84 | -20 | +520.0% |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 2,967 | 2,999 | -1.1% |
Values in millions USD. Source: SEC EDGAR 10-Q filing.